Clinical Trial Detail

NCT ID NCT03944941
Title Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance for Clinical Trials in Oncology
Indications

skin squamous cell carcinoma

Therapies

Avelumab

Avelumab + Cetuximab

Age Groups: adult senior

No variant requirements are available.